168 related articles for article (PubMed ID: 31965268)
21. PIWIL1 governs the crosstalk of cancer cell metabolism and immunosuppressive microenvironment in hepatocellular carcinoma.
Wang N; Tan HY; Lu Y; Chan YT; Wang D; Guo W; Xu Y; Zhang C; Chen F; Tang G; Feng Y
Signal Transduct Target Ther; 2021 Feb; 6(1):86. PubMed ID: 33633112
[TBL] [Abstract][Full Text] [Related]
22. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1.
Hua S; Lei L; Deng L; Weng X; Liu C; Qi X; Wang S; Zhang D; Zou X; Cao C; Liu L; Wu D
Oncogene; 2018 Mar; 37(12):1624-1636. PubMed ID: 29335523
[TBL] [Abstract][Full Text] [Related]
23. Loss of PTEN expression is associated with PI3K pathway-dependent metabolic reprogramming in hepatocellular carcinoma.
Zhao C; Wang B; Liu E; Zhang Z
Cell Commun Signal; 2020 Aug; 18(1):131. PubMed ID: 32831114
[TBL] [Abstract][Full Text] [Related]
24. Full-length soluble CD147 promotes MMP-2 expression and is a potential serological marker in detection of hepatocellular carcinoma.
Wu J; Hao ZW; Zhao YX; Yang XM; Tang H; Zhang X; Song F; Sun XX; Wang B; Nan G; Chen ZN; Bian H
J Transl Med; 2014 Jul; 12():190. PubMed ID: 24996644
[TBL] [Abstract][Full Text] [Related]
25. Cluster of differentiation 147 is a key molecule during hepatocellular carcinoma cell-hepatic stellate cell cross-talk in the rat liver.
Ma T; Wang Z; Yang Z; Chen J
Mol Med Rep; 2015 Jul; 12(1):111-8. PubMed ID: 25738354
[TBL] [Abstract][Full Text] [Related]
26. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
[TBL] [Abstract][Full Text] [Related]
27. Reprograming of Glucose Metabolism by Zerumbone Suppresses Hepatocarcinogenesis.
Wani NA; Zhang B; Teng KY; Barajas JM; Motiwala T; Hu P; Yu L; Brüschweiler R; Ghoshal K; Jacob ST
Mol Cancer Res; 2018 Feb; 16(2):256-268. PubMed ID: 29187559
[TBL] [Abstract][Full Text] [Related]
28. Down-Regulated miR-125a-5p Promotes the Reprogramming of Glucose Metabolism and Cell Malignancy by Increasing Levels of CD147 in Thyroid Cancer.
Huang P; Mao LF; Zhang ZP; Lv WW; Feng XP; Liao HJ; Dong C; Kaluba B; Tang XF; Chang S
Thyroid; 2018 May; 28(5):613-623. PubMed ID: 29634399
[TBL] [Abstract][Full Text] [Related]
29. FOXM1 regulates glycolysis in hepatocellular carcinoma by transactivating glucose transporter 1 expression.
Shang R; Pu M; Li Y; Wang D
Oncol Rep; 2017 Apr; 37(4):2261-2269. PubMed ID: 28260073
[TBL] [Abstract][Full Text] [Related]
30. YIPF2 is a novel Rab-GDF that enhances HCC malignant phenotypes by facilitating CD147 endocytic recycle.
Qi S; Su L; Li J; Zhao P; Zhang Q; Niu X; Liu J; Jia G; Wei X; Tavernier J; Jiang J; Chen Z; Zhang S
Cell Death Dis; 2019 Jun; 10(6):462. PubMed ID: 31189879
[TBL] [Abstract][Full Text] [Related]
31. ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM.
Zhou Y; Lin F; Wan T; Chen A; Wang H; Jiang B; Zhao W; Liao S; Wang S; Li G; Xu Z; Wang J; Zhang J; Ma H; Lin D; Li Q
Theranostics; 2021; 11(12):5926-5938. PubMed ID: 33897890
[TBL] [Abstract][Full Text] [Related]
32. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
Dai W; Xu L; Yu X; Zhang G; Guo H; Liu H; Song G; Weng S; Dong L; Zhu J; Liu T; Guo C; Shen X
J Hepatol; 2020 May; 72(5):909-923. PubMed ID: 31899205
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of PCK1 Gene Antagonizes Hepatocellular Carcinoma Through the Activation of Gluconeogenesis and Suppression of Glycolysis Pathways.
Tang Y; Zhang Y; Wang C; Sun Z; Li L; Cheng S; Zhou W
Cell Physiol Biochem; 2018; 47(1):344-355. PubMed ID: 29768256
[TBL] [Abstract][Full Text] [Related]
34. Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells.
Cao TT; Lin SH; Fu L; Tang Z; Che CM; Zhang LY; Ming XY; Liu TF; Tang XM; Tan BB; Xiang D; Li F; Chan OY; Xie D; Cai Z; Guan XY
Carcinogenesis; 2017 Jan; 38(1):94-104. PubMed ID: 27879277
[TBL] [Abstract][Full Text] [Related]
35. Basolateral CD147 induces hepatocyte polarity loss by E-cadherin ubiquitination and degradation in hepatocellular carcinoma progress.
Lu M; Wu J; Hao ZW; Shang YK; Xu J; Nan G; Li X; Chen ZN; Bian H
Hepatology; 2018 Jul; 68(1):317-332. PubMed ID: 29356040
[TBL] [Abstract][Full Text] [Related]
36. Down-regulated lncRNA TP73-AS1 reduces radioresistance in hepatocellular carcinoma via the PTEN/Akt signaling pathway.
Song W; Zhang J; Xia Q; Sun M
Cell Cycle; 2019 Nov; 18(22):3177-3188. PubMed ID: 31564201
[No Abstract] [Full Text] [Related]
37. Loss of miR-192-5p initiates a hyperglycolysis and stemness positive feedback in hepatocellular carcinoma.
Gu Y; Ji F; Liu N; Zhao Y; Wei X; Hu S; Jia W; Wang XW; Budhu A; Ji J; Zhao B; Roessler S; Zheng X; Ji J
J Exp Clin Cancer Res; 2020 Nov; 39(1):268. PubMed ID: 33256802
[TBL] [Abstract][Full Text] [Related]
38. FLIP(L) is critical for aerobic glycolysis in hepatocellular carcinoma.
Lei S; Yang J; Chen C; Sun J; Yang L; Tang H; Yang T; Chen A; Zhao H; Li Y; Du X
J Exp Clin Cancer Res; 2016 May; 35():79. PubMed ID: 27178057
[TBL] [Abstract][Full Text] [Related]
39. Small nucleolar RNA ACA11 promotes proliferation, migration and invasion in hepatocellular carcinoma by targeting the PI3K/AKT signaling pathway.
Wu L; Zheng J; Chen P; Liu Q; Yuan Y
Biomed Pharmacother; 2017 Jun; 90():705-712. PubMed ID: 28419966
[TBL] [Abstract][Full Text] [Related]
40. Phosphoglucomutase 1 inhibits hepatocellular carcinoma progression by regulating glucose trafficking.
Jin GZ; Zhang Y; Cong WM; Wu X; Wang X; Wu S; Wang S; Zhou W; Yuan S; Gao H; Yu G; Yang W
PLoS Biol; 2018 Oct; 16(10):e2006483. PubMed ID: 30335765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
